Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

971 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
First-line 5-fluorouracil/folinic acid, oxaliplatin and irinotecan (FOLFOXIRI) does not impair the feasibility and the activity of second line treatments in metastatic colorectal cancer.
Masi G, Marcucci L, Loupakis F, Cerri E, Barbara C, Bursi S, Allegrini G, Brunetti IM, Murr R, Ricci S, Cupini S, Andreuccetti M, Falcone A. Masi G, et al. Among authors: ricci s. Ann Oncol. 2006 Aug;17(8):1249-54. doi: 10.1093/annonc/mdl119. Epub 2006 Jun 9. Ann Oncol. 2006. PMID: 16766580 Free article. Clinical Trial.
First-line treatment of metastatic colorectal cancer with irinotecan, oxaliplatin and 5-fluorouracil/leucovorin (FOLFOXIRI): results of a phase II study with a simplified biweekly schedule.
Masi G, Allegrini G, Cupini S, Marcucci L, Cerri E, Brunetti I, Fontana E, Ricci S, Andreuccetti M, Falcone A. Masi G, et al. Among authors: ricci s. Ann Oncol. 2004 Dec;15(12):1766-72. doi: 10.1093/annonc/mdh470. Ann Oncol. 2004. PMID: 15550581 Free article. Clinical Trial.
A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer.
Vasile E, Masi G, Fornaro L, Cupini S, Loupakis F, Bursi S, Petrini I, Di Donato S, Brunetti IM, Ricci S, Antonuzzo A, Chiara S, Amoroso D, Andreuccetti M, Falcone A. Vasile E, et al. Among authors: ricci s. Br J Cancer. 2009 Jun 2;100(11):1720-4. doi: 10.1038/sj.bjc.6605075. Epub 2009 May 12. Br J Cancer. 2009. PMID: 19436300 Free PMC article. Clinical Trial.
Continuous-infusion 5-fluorouracil in metastatic colorectal cancer patients pretreated with bolus 5-fluorouracil: clinical evidence of incomplete cross-resistance.
Falcone A, Cianci C, Pfanner E, Bertuccelli M, Brunetti I, Muttini MP, Dargenio F, Ricci S, Conte PF. Falcone A, et al. Among authors: ricci s. Ann Oncol. 1994 Mar;5(3):291. doi: 10.1093/oxfordjournals.annonc.a058813. Ann Oncol. 1994. PMID: 8186179 Free article. Clinical Trial. No abstract available.
Increased dose-intensity of gemcitabine in advanced non small cell lung cancer (NSCLC): a multicenter phase II study in elderly patients from the "polmone toscano group" (POLTO).
Tibaldi C, Ricci S, Russo F, Bernardini I, Galli L, Chioni A, Orlandini C, Grosso AM, Pegna AL, Fabbri A, Innocenti F, Ferrari K, Tognarini L, Conte PF, Falcone A; POLTO group. Tibaldi C, et al. Among authors: ricci s. Lung Cancer. 2005 Apr;48(1):121-7. doi: 10.1016/j.lungcan.2004.10.008. Epub 2004 Dec 10. Lung Cancer. 2005. PMID: 15777979 Clinical Trial.
971 results